Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation

Clinical trial NCT06110572 · RECRUITING

Trial details

NCT number: NCT06110572
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extensive Stage Lung Small Cell Carcinoma Stage IV Lung Cancer

Start date: 2024-04-24
Primary completion: 2027-06-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.